Reader Comments

Post a new comment on this article


Posted by ilpicardhotmail on 18 Aug 2013 at 15:05 GMT

Because of the development of dalfampridine at McMaster University and of the position of the corresponding author in that institution, I think that the obvious conflict of interest should be declared.

No competing interests declared.